Examining Patient Involvement Patterns and Trends in Participation in Bone Cancer Clinical Trials
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Bone Cancer
- Sponsor
- Power Life Sciences Inc.
- Enrollment
- 500
- Locations
- 1
- Primary Endpoint
- Rate of patients who decide to enroll in a bone cancer clinical research.
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
Clinical studies, with a distinct focus on bone cancer, play a crucial role in evaluating the safety and effectiveness of novel treatments for this disease. These trials serve as instrumental means to determine whether new medications surpass conventional therapies, providing substantial evidence for their broader adoption.
The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
- •Diagnosis of bone cancer
- •No prior treatment for bone cancer
Exclusion Criteria
- •Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
- •Enrolled in another research study
- •Inability to provide written informed consent
Outcomes
Primary Outcomes
Rate of patients who decide to enroll in a bone cancer clinical research.
Time Frame: 3 months
Number of bone cancer study participants who remain in clinical study until completion.
Time Frame: 12 months